$22.5
Insights on Trupanion, Inc.
Revenue is up for the last 16 quarters, 111.30M → 295.85M (in $), with an average increase of 6.3% per quarter
Netprofit is up for the last 4 quarters, -24.78M → -2.16M (in $), with an average increase of 135.7% per quarter
In the last 1 year, Assurant Inc. has given 41.7% return, outperforming this stock by 81.2%
In the last 3 years, Assurant Inc. has given 12.1% return, outperforming this stock by 84.4%
1.11%
Downside
Day's Volatility :6.94%
Upside
5.9%
18.0%
Downside
52 Weeks Volatility :50.31%
Upside
39.4%
Period | Trupanion, Inc. | Sector (Financials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -12.41% | 4.0% | 0.0% |
6 Months | 17.3% | 23.9% | 0.0% |
1 Year | -35.41% | 22.0% | 0.0% |
3 Years | -70.63% | 11.3% | -21.9% |
Market Capitalization | 999.8M |
Book Value | $7.26 |
Earnings Per Share (EPS) | -1.08 |
PEG Ratio | 0.0 |
Wall Street Target Price | 35.0 |
Profit Margin | -4.03% |
Operating Margin TTM | 0.17% |
Return On Assets TTM | -3.12% |
Return On Equity TTM | -14.68% |
Revenue TTM | 1.1B |
Revenue Per Share TTM | 26.75 |
Quarterly Revenue Growth YOY | 20.3% |
Gross Profit TTM | 32.7M |
EBITDA | -23.8M |
Diluted Eps TTM | -1.08 |
Quarterly Earnings Growth YOY | -0.33 |
EPS Estimate Current Year | -0.45 |
EPS Estimate Next Year | 0.05 |
EPS Estimate Current Quarter | -0.18 |
EPS Estimate Next Quarter | -0.14 |
What analysts predicted
Upside of 55.56%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 304.0M | ↑ 25.26% |
Net Income | -927.0K | ↓ 38.32% |
Net Profit Margin | -0.3% | ↑ 0.32% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 383.9M | ↑ 26.31% |
Net Income | -1.8M | ↑ 95.15% |
Net Profit Margin | -0.47% | ↓ 0.17% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 502.0M | ↑ 30.76% |
Net Income | -5.8M | ↑ 222.83% |
Net Profit Margin | -1.16% | ↓ 0.69% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 699.0M | ↑ 39.23% |
Net Income | -35.5M | ↑ 508.39% |
Net Profit Margin | -5.08% | ↓ 3.92% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 905.2M | ↑ 29.5% |
Net Income | -44.7M | ↑ 25.73% |
Net Profit Margin | -4.94% | ↑ 0.14% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 22.47% |
Net Income | -44.7M | ↑ 0.05% |
Net Profit Margin | -4.03% | ↑ 0.91% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 233.8M | ↑ 6.54% |
Net Income | -12.9M | ↓ 5.17% |
Net Profit Margin | -5.52% | ↑ 0.69% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 246.0M | ↑ 5.24% |
Net Income | -9.3M | ↓ 28.1% |
Net Profit Margin | -3.77% | ↑ 1.75% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 256.3M | ↑ 4.19% |
Net Income | -24.8M | ↑ 166.88% |
Net Profit Margin | -9.67% | ↓ 5.9% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 270.6M | ↑ 5.55% |
Net Income | -13.7M | ↓ 44.66% |
Net Profit Margin | -5.07% | ↑ 4.6% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 285.9M | ↑ 5.65% |
Net Income | -4.0M | ↓ 70.57% |
Net Profit Margin | -1.41% | ↑ 3.66% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 295.9M | ↑ 3.5% |
Net Income | -2.2M | ↓ 46.41% |
Net Profit Margin | -0.73% | ↑ 0.68% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 207.5M | ↑ 96.02% |
Total Liabilities | 78.3M | ↑ 36.42% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 257.2M | ↑ 23.95% |
Total Liabilities | 120.4M | ↑ 53.75% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 498.3M | ↑ 93.72% |
Total Liabilities | 158.3M | ↑ 31.44% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 562.6M | ↑ 12.91% |
Total Liabilities | 230.4M | ↑ 45.52% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 671.6M | ↑ 19.38% |
Total Liabilities | 366.3M | ↑ 59.01% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 782.9M | ↑ 16.57% |
Total Liabilities | 479.2M | ↑ 30.82% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 647.9M | ↑ 2.0% |
Total Liabilities | 342.2M | ↑ 6.79% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 671.6M | ↑ 3.66% |
Total Liabilities | 366.3M | ↑ 7.06% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 717.9M | ↑ 6.89% |
Total Liabilities | 423.1M | ↑ 15.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 730.2M | ↑ 1.71% |
Total Liabilities | 441.4M | ↑ 4.33% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 772.0M | ↑ 5.73% |
Total Liabilities | 482.6M | ↑ 9.32% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 782.9M | ↑ 1.41% |
Total Liabilities | 479.2M | ↓ 0.69% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 12.7M | ↑ 31.18% |
Investing Cash Flow | -81.5M | ↑ 523.86% |
Financing Cash Flow | 71.2M | ↑ 1301.87% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 16.2M | ↑ 27.42% |
Investing Cash Flow | -28.0M | ↓ 65.61% |
Financing Cash Flow | 14.0M | ↓ 80.28% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 21.5M | ↑ 33.34% |
Investing Cash Flow | -76.7M | ↑ 174.02% |
Financing Cash Flow | 170.8M | ↑ 1116.52% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.5M | ↓ 65.38% |
Investing Cash Flow | -51.9M | ↓ 32.36% |
Financing Cash Flow | -1.1M | ↓ 100.66% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.0M | ↓ 207.27% |
Investing Cash Flow | -67.5M | ↑ 30.06% |
Financing Cash Flow | 60.7M | ↓ 5499.38% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.3M | ↓ 26.55% |
Investing Cash Flow | -11.8M | ↑ 8.64% |
Financing Cash Flow | -710.0K | ↓ 88.15% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.0M | ↓ 144.32% |
Investing Cash Flow | -30.6M | ↑ 158.32% |
Financing Cash Flow | 14.7M | ↓ 2167.89% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -6.9M | ↓ 773.41% |
Investing Cash Flow | 33.9M | ↓ 211.0% |
Financing Cash Flow | 33.8M | ↑ 130.28% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -3.4M | ↓ 50.38% |
Investing Cash Flow | -5.5M | ↓ 116.3% |
Financing Cash Flow | -93.0K | ↓ 100.28% |
Sell
Neutral
Buy
Trupanion, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Trupanion, Inc. | -12.38% | 17.3% | -35.41% | -70.63% | -27.69% |
Ryan Specialty Holdings Inc | -9.0% | 14.29% | 19.84% | 79.42% | 79.42% |
First American Financial Corporation | -10.33% | 2.9% | -6.95% | -18.6% | -5.39% |
Assurant Inc. | -6.85% | 4.76% | 41.73% | 10.53% | 85.28% |
Essent Group Ltd | -10.02% | 10.84% | 24.81% | 0.46% | 12.01% |
Fidelity National Financial, Inc. | -6.44% | 22.74% | 40.11% | 7.19% | 25.19% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Trupanion, Inc. | NA | NA | 0.0 | -0.45 | -0.15 | -0.03 | NA | 7.26 |
Ryan Specialty Holdings Inc | 97.65 | 95.81 | NA | 1.77 | 0.22 | 0.04 | 0.01 | 4.72 |
First American Financial Corporation | 27.91 | 27.91 | 2.04 | 4.17 | 0.05 | 0.02 | 0.04 | 47.02 |
Assurant Inc. | 14.82 | 14.47 | 1.46 | 15.57 | 0.14 | 0.02 | 0.02 | 92.57 |
Essent Group Ltd | 8.33 | 8.33 | 0.84 | 6.59 | 0.15 | 0.09 | 0.02 | 47.87 |
Fidelity National Financial, Inc. | 26.51 | 26.51 | 10.83 | 4.75 | 0.07 | 0.01 | 0.04 | 25.28 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Trupanion, Inc. | Buy | $999.8M | -27.69% | NA | -4.03% |
Ryan Specialty Holdings Inc | Buy | $13.2B | 79.42% | 97.65 | 3.01% |
First American Financial Corporation | Buy | $6.0B | -5.39% | 27.91 | 3.61% |
Assurant Inc. | Buy | $9.2B | 85.28% | 14.82 | 5.77% |
Essent Group Ltd | Buy | $5.8B | 12.01% | 8.33 | 64.18% |
Fidelity National Financial, Inc. | Buy | $13.8B | 25.19% | 26.51 | 4.39% |
BlackRock Inc
Capital World Investors
Vanguard Group Inc
Aflac Inc
Flossbach von Storch AG
Wellington Management Company LLP
Trupanion, Inc.’s price-to-earnings ratio stands at None
Read Moretrupanion is the fastest growing player in the pet medical insurance space. we are known for superior coverage and top-notch customer service. we pride ourselves on swift claims resolutions and providing the best medical insurance care available. if you are a pet lover seeking your next adventure, then you have found a company that’s right for you! we're growing our footprint throughout north america and need ambitious, data-driven individuals with innovation in their dna to join our team and help nurture a market with immense opportunity. as a territory partner you can enjoy the freedom and flexibility of being your own boss while spearheading the growth of medical insurance for pets in your region. as a team member at our headquarters you will find yourself surrounded by supportive colleagues (and furry companions) and managers who want to help you find your sweet spot, aligning your passion for animals and professional skills. both employment opportunities will allow you to position
Organization | Trupanion, Inc. |
Employees | 1142 |
CEO | Mr. Darryl Graham Andrew Rawlings |
Industry | Finance |